Abstract

Needle-shaped crystals, typified by aspect ratios of (1:1:100–1000) are often the steady-state growth shapes in the crystallization of active pharmaceutical ingredients from solution. Crystals with such high aspect ratio shapes are troublesome in the subsequent processing steps required in the formation of a drug product. Therefore, the ability to design crystallizations that directly avoid the formation of needles is of significant interest. In this article, a causality for the formation of needles and guidance for solvent selection based on this causality are provided. The causality presented in this article was formed based on a spiral growth model and requires the presence of a single strongest periodic bond chain within the lattice that is parallel to the direction of elongation of the crystal. The article provides a method for predicting the formation of a needle for a given solute–solvent system based on this causality. Furthermore, three case studies are provided that demonstrate good agreement between experimentally obtained and predicted shapes. As a result, generalized guidance for solvent selection based on the objective of avoiding needles is provided.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.